If Approved by the Dept. of Health, New Mexico Would Join 13 Other States Where Patients Can Access Medical Cannabis for Alzheimer’s Disease
SANTA FE—Yesterday, the New Mexico Medical Cannabis Program’s Medical Advisory Board voted unanimously to add neurodegenerative dementia including Alzheimer’s disease (AD) to the list of medical conditions eligible for the Medical Cannabis Program. The Secretary of Health will have the final decision. Medical cannabis is currently available to Alzheimer’s patients in thirteen of the states that authorize its use.
April 24, 2014
Drug Policy Alliance